BioStem Technologies, Inc.

BiotechnologyBiotechnologyRegenerative MedicineAllografts

📍 Pompano Beach, FL, United States

StreetZero Signal 75

Be the first to signal interest

About BioStem Technologies, Inc.

BioStem Technologies, Inc. (OTC Pink: BSEM) is a biotechnology company focused on developing, manufacturing, and commercializing placental-derived allografts for advanced wound care and regenerative therapies in the United States. It harnesses perinatal tissue using its proprietary BioREtain® processing method along with CryoTek® and SteriTek® technologies to preserve natural tissue properties. The company offers products including Vendaje, Vendaje AC, Vendaje OPTIC, American Amnion AC, and American Amnion for wound covering and homologous use. It maintains a national commercial footprint and is headquartered in Pompano Beach, FL.

LATEST FUNDINGPrivate Placement

$3.0M

Announced 2026-10-09

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for BioStem Technologies, Inc..

Create free account Sign in

Free plan includes 3 full deal profiles every month.

IN THE NEWS

EMPLOYEES—

FOUNDED—

HQPompano Beach, FL, United States

Industry

Biotechnology

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Develops and commercializes human perinatal tissue allografts using proprietary BioREtain processing for regenerative therapies.
Publicly traded on OTC Pink as BSEM with a portfolio including Vendaje and American Amnion products.
Completed a $3,000,000 private placement with undisclosed investors.
Headquartered in Pompano Beach, FL and serves the U.S. healthcare market through medical provider channels.
Employs BioREtain, CryoTek, and SteriTek technologies to optimize tissue preservation.